Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$864M |
| 2 |
JPMorgan Chase
JPM
|
+$721M |
| 3 |
PepsiCo
PEP
|
+$637M |
| 4 |
ExxonMobil
XOM
|
+$604M |
| 5 |
American Electric Power
AEP
|
+$596M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$396M |
| 2 |
Wells Fargo
WFC
|
+$374M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$322M |
| 4 |
Alibaba
BABA
|
+$306M |
| 5 |
Oracle
ORCL
|
+$305M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Healthcare | 15.31% |
| 3 | Financials | 10.49% |
| 4 | Consumer Discretionary | 9.14% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Newell Brands
NWL
$2.16B
| $155M | 0.08% |
9,057,064
+72,218
| +0.8% | +$1.2M |
|
|
HZNP
277
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $155M | 0.08% |
1,997,236
+670,254
| +51% | +$46.1M |
|
278
British American Tobacco
BTI
$132B
| $155M | 0.07% |
4,280,658
+12,464
| +0.3% | +$436K |
|
279
Enbridge
ENB
$124B
| $153M | 0.07% |
5,256,761
-177,776
| -3% | -$5.59M |
|
280
Scotiabank
BNS
$106B
| $153M | 0.07% |
3,678,642
-143,351
| -4% | -$6.01M |
|
|
NBIS
281
Nebius Group N.V.
NBIS
$47.7B
| $152M | 0.07% |
2,331,691
-213,438
| -8% | -$12.7M |
|
282
Donaldson
DCI
$10.8B
| $151M | 0.07% |
3,259,111
-11,087
| -0.3% | -$539K |
|
|
IMMU
283
DELISTED
Immunomedics Inc
IMMU
| $150M | 0.07% |
1,769,944
-675,642
| -28% | -$34.2M |
|
284
Haemonetics
HAE
$3.58B
| $150M | 0.07% |
1,723,851
+438,864
| +34% | +$38.4M |
|
285
Franklin High Yield Corporate ETF
FLHY
$1.21B
| $150M | 0.07% |
5,931,184
+125,610
| +2% | +$3.2M |
|
|
BKI
286
DELISTED
Black Knight, Inc. Common Stock
BKI
| $149M | 0.07% |
1,713,394
+74,862
| +5% | +$5.9M |
|
287
Franklin FTSE Japan ETF
FLJP
$3.93B
| $149M | 0.07% |
5,690,653
+119,081
| +2% | +$3.02M |
|
|
SRE.PRB
288
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $149M | 0.07% |
1,516,750
+100,100
| +7% | +$10.3M |
|
289
Guardant Health
GH
$19.5B
| $148M | 0.07% |
1,326,049
+429,441
| +48% | +$39.3M |
|
290
Southwest Airlines
LUV
$22.1B
| $148M | 0.07% |
3,945,766
+3,460,649
| +713% | +$123M |
|
|
AYX
291
DELISTED
Alteryx Inc
AYX
| $148M | 0.07% |
1,301,724
-142,463
| -10% | -$19.4M |
|
292
Neurocrine Biosciences
NBIX
$17.7B
| $147M | 0.07% |
1,530,160
+77,878
| +5% | +$9.01M |
|
|
NVRO
293
DELISTED
NEVRO CORP.
NVRO
| $147M | 0.07% |
1,052,266
-35,338
| -3% | -$4.72M |
|
294
Bank of Montreal
BMO
$125B
| $146M | 0.07% |
2,501,656
-93,088
| -4% | -$5.39M |
|
295
Schwab Short-Term US Treasury ETF
SCHO
$12.7B
| $146M | 0.07% |
5,665,050
+224,750
| +4% | +$5.79M |
|
296
Aflac
AFL
$63.9B
| $146M | 0.07% |
4,011,292
+34,722
| +0.9% | +$1.26M |
|
297
Evergy
EVRG
$20.1B
| $145M | 0.07% |
2,852,759
+293,049
| +11% | +$16.4M |
|
298
BorgWarner
BWA
$13.2B
| $145M | 0.07% |
4,247,278
+597,290
| +16% | +$20.5M |
|
299
PUT
iShares MSCI EAFE ETF
EFA
$76.4B
| $144M | 0.07% |
2,269,000
+956,400
| +73% | +$61.2M |
|
300
Agilent Technologies
A
$39.1B
| $144M | 0.07% |
1,430,108
+6,066
| +0.4% | +$586K |
|
Similar funds
Franklin Resources's Q3 2020 Portfolio in Review
As of Q3 2020, Franklin Resources held 1,922 positions worth $207B, up 6.4% from $194B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Franklin Resources's Q3 2020 filing shows 241 new, 817 increased, 586 reduced and 63 closed positions. Its largest new stake was NextEra Energy, Inc. 6.219% Corporate Units: 6,330,200 shares worth $302M. The largest sale was Pfizer, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Franklin Resources's largest Q3 2020 buy was NextEra Energy, Inc. 6.219% Corporate Units: 6,330,200 shares worth $302M.
- Franklin Resources added most to Chevron in Q3 2020, an estimated $864M increase.
- Franklin Resources's biggest Q3 2020 reduction was Pfizer, cutting an estimated $396M.
- Franklin Resources fully exited Signature Bank in Q3 2020, selling an estimated $72.1M.
- Franklin Resources's ten largest holdings make up 14% of its $207B portfolio in Q3 2020.
- Franklin Resources opened 241 new positions and closed 63 in Q3 2020.
- Franklin Resources's portfolio value rose 6.4% quarter-over-quarter to $207B.
Based on Franklin Resources's 13F filing for Q3 2020, filed 12 Nov 2020.